Is PAOG or PFE a better dividend investment in 2026?

PAOG currently yields 666666.67% with a 5% 5-year dividend growth rate. PFE yields 6.13% with 4.1% growth. The better choice depends on your goal: PAOG offers higher current income.

What is the dividend yield difference between PAOG and PFE?

PAOG has a forward dividend yield of 666666.67% ($2.00/share annually). PFE yields 6.13% ($1.72/share annually). The yield gap is 666660.54 percentage points.

Home › Compare › PAOG vs PFE

PAOG vs PFE: Dividend Comparison 2026

PAOG yields 666666.67% · PFE yields 6.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PAOG wins by $8.275235618773884e+34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PAOG

● Live price

666666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.275235618773884e+34M

Annual income

$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00

Full PAOG calculator →

PFE

Pfizer Inc.

● Live price

6.13%

Share price

$28.08

Annual div

$1.72

5Y div CAGR

13.2%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$49.6K

Annual income

$26,258.71

Full PFE calculator →

Portfolio growth — PAOG vs PFE

📍 PAOG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PAOG	PFE
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PAOG + PFE cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PAOG pays

PFE pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PAOG

Annual income on $10K today (after 15% tax)

$56,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr

PFE

Annual income on $10K today (after 15% tax)

$520.66/yr

After 10yr DRIP, annual income (after tax)

$22,319.90/yr

At 15% tax rate, PAOG beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PAOG + PFE for your $10,000?

PAOG: 50%PFE: 50%

100% PFE50/50100% PAOG

Portfolio after 10yr

$4.137617809386942e+34M

Annual income

$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.97%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PAOG

No analyst data

Altman Z

-5941.4

Piotroski

4/9

PFE

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$27.50

-2.1% upside vs current

Range: $24.00 — $35.00

Altman Z

2.0

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PAOG buys

PFE buys

No recent congressional trades found for PAOG or PFE in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPAOGPFE

Forward yield	666666.67% ✓	6.13%
Annual dividend / share	$2.00 ✓	$1.72
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	13.2% ✓
Portfolio after 10y	$8.275235618773884e+34M	$49.6K ✓
Annual income after 10y	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓	$26,258.71
Total dividends collected	$8.275075881065991e+34M	$58.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: PAOG vs PFE ($10,000, DRIP)

Year	PAOG Portfolio	PAOG Income/yr	PFE Portfolio	PFE Income/yr	Gap
1← crossover	$66,677,367	$66,666,666.67	$9,153	$693.39	+$66.67M → PAOG
2	$415,506,651,117	$415,435,306,334.37	$8,593	$849.25	+$415506.64M → PAOG
3	$2,419,908,598,386,268	$2,419,464,006,269,573.00	$8,336	$1,066.78	+$2419908598.38M → PAOG
4	$13,171,697,643,084,456,000	$13,169,108,340,884,183,000.00	$8,437	$1,384.80	+$13171697643084.45M → PAOG
5	$67,004,927,492,790,120,000,000	$66,990,833,776,312,020,000,000.00	$9,013	$1,875.40	+$67004927492790120.00M → PAOG
6	$318,562,277,003,514,840,000,000,000	$318,490,581,731,097,560,000,000,000.00	$10,306	$2,680.72	+$318562277003514871808.00M → PAOG
7	$1,415,484,168,853,553,000,000,000,000,000	$1,415,143,307,217,159,200,000,000,000,000.00	$12,820	$4,101.38	+$1.415484168853553e+24M → PAOG
8	$5,878,130,573,362,507,000,000,000,000,000,000	$5,876,616,005,301,833,000,000,000,000,000,000.00	$17,673	$6,826.70	+$5.878130573362507e+27M → PAOG
9	$22,813,793,009,840,743,000,000,000,000,000,000,000	$22,807,503,410,127,248,000,000,000,000,000,000,000.00	$27,543	$12,591.86	+$2.2813793009840744e+31M → PAOG
10	$82,752,356,187,738,840,000,000,000,000,000,000,000,000	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00	$49,560	$26,258.71	+$8.275235618773884e+34M → PAOG

PAOG vs PFE: Complete Analysis 2026

PAOG — Stock

PAO Group, Inc. focuses on alternative patient care treatments. The company, through its subsidiaries, engages in the development, sale, and distribution of premium medical cannabis products for treatment of chronic and terminal patients. The company is headquartered in Sandusky, Ohio.

Full PAOG Calculator →

PFE — Healthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →

📬

Get this PAOG vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PAOG vs SCHD PAOG vs JEPI PAOG vs O PAOG vs KO PAOG vs MAIN PAOG vs JNJ PAOG vs MRK PAOG vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.